Combination of Anastrozole and Fulvestrant in Metastatic Breast Cancer

A phase III trial conducted by SWOG found that the combination of fulvestrant and anastrozole significantly improved survival compared to anastrozole alone. These results rendered several potentially practice changing implications, which are discussed by the panel in this segment.

For more from this discussion, visit http://www.onclive.com/peer-ex....change/MBC-challenge